UNSPSC 51284138: Cefpiramide sodium

This classification denotes a cephalosporin antibiotic with the molecular formula C25H23N8O7S2.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 137KB7GYKB, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((((4-hydroxy-6-methyl-3-pyridinyl)carbonyl)amino)(4-hydroxyphenyl)acetyl)amino)-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, monosodium salt, (6r-(6alpha,7beta(r*)))- but more generally known as cefpiramide sodium, which bears US NIH Compound Identifier 53129.

UNSPSC 51284138 Cefpiramide sodium is a Commodity code that designates a specific pharmaceutical active pharmaceutical ingredient, yet recent state and local procurement activity under this code shows minimal relevance to the code's nominal scope. The opportunities posted in the source involve pharmaceutical procurement by state health departments and county health authorities, but neither opportunity actually solicits cefpiramide sodium; instead, they address unrelated pharmaceutical products and medical supplies including antibiotics (doxycycline, ciprofloxacin), naloxone, and drug deactivation systems. The mismatch suggests either tagging inconsistency in state and local procurement systems or that this code sees little active use for its intended commodity.

The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract to Chartwell Rx LLC in August 2026 for doxycycline and ciprofloxacin through the MMCAP Infuse cooperative purchasing vehicle, with a total award value of $2,999,999.11 over 12 months plus two optional renewal years. Seminole County, Florida posted an Invitation for Bid in June 2026 (due date July 26, 2023 — a historical data anomaly) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building. Activity appears limited to Florida and Illinois, with no additional states represented in the recent-opportunities block. The code shows no current open solicitations for cefpiramide sodium itself; business development professionals should verify whether this code remains active in state and local procurement systems or whether pharmaceutical suppliers should monitor alternative taxonomy paths for antibiotic formulation opportunities.